Documentdetail
ID kaart
oai:pubmedcentral.nih.gov:1107...
Onderwerp
Review ArticlesAuteur
Nazir, SophiaLangue
enEditor
John Wiley and Sons Inc.
Categorie
Aging Medicine
Jaar
2024
vermelding datum
10-06-2024
Trefwoorden
alzheimer saliva diseaseBeschrijving
The precise identification of Alzheimer's disease and other prevalent neurodegenerative diseases remains a difficult issue that requires the development of early detection of the disease and inexpensive biomarkers that can replace the present cerebrospinal fluid and imaging biomarkers.
Blood biomarkers, such as amyloid and neurofilament light, have been emphasized as an important and practical tool in a testing or examination procedure thanks to advancements in ultra‐sensitive detection techniques.
Although saliva is not currently being researched for neurodegenerative diseases, it is an important source of biomarkers that can be used for the identification of diseases and has some advantages over other biofluids.
While this may be true for most people, getting saliva from elderly people presents some significant challenges.
In this overview, we will first discuss how saliva is created and how aging‐related illnesses may affect the amount and kind of saliva produced.
The findings support the use of salivary amyloid protein, tau species, and novel biomarkers in the diagnosis of Alzheimer's disease.
Nazir, Sophia, 2024, Salivary biomarkers: The early diagnosis of Alzheimer's disease, John Wiley and Sons Inc.
UniZero: Generalized and Efficient Planning with Scalable Latent World Models
unizero latent learning
Reconstruction of the Corticospinal Tract in Patients with Motor-Eloquent High-Grade Gliomas Using Multilevel Fiber Tractography Combined with Functional Motor Cortex Mapping
mapping motor-eloquent threshold anisotropy spherical gliomas patients corticospinal tract tractography
